Literature DB >> 2794863

Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus.

S M Breathnach1, H Kofler, N Sepp, J Ashworth, D Woodrow, M B Pepys, H Hintner.   

Abstract

Serum amyloid P component (SAP) is the single plasma protein that, from the milieu of whole normal human serum, undergoes specific calcium-dependent binding to isolated DNA and chromatin in vitro. We now report for the first time that SAP in whole serum also undergoes calcium-dependent binding to nuclei of epidermal cells in sections of normal human skin and to nuclei of fixed Hep-2 cells, a human epithelial cell line. Furthermore, and most importantly, SAP was detected in association with unusual globular dermal deposits of nuclear material in skin biopsies from two patients with systemic lupus erythematosus. This is the first evidence for binding of SAP to extracellular chromatin in vivo and supports the idea that SAP may have an important physiological role in the disposal of this material.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794863      PMCID: PMC2189460          DOI: 10.1084/jem.170.4.1433

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Tissue amyloid P component in normal human dermis is non-covalently associated with elastic fiber microfibrils.

Authors:  S M Breathnach; M B Pepys; H Hintner
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

2.  Experimental skin lesions in mice resembling systemic lupus erythematosus.

Authors:  P G Natali; E M Tan
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

3.  The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice.

Authors:  J N Gilliam
Journal:  J Invest Dermatol       Date:  1975-07       Impact factor: 8.551

Review 4.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

5.  Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein.

Authors:  F A Robey; K D Jones; T Tanaka; T Y Liu
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

6.  Amyloid P component is located on elastic fibre microfibrils in normal human tissue.

Authors:  S M Breathnach; S M Melrose; B Bhogal; F C de Beer; R F Dyck; G Tennent; M M Black; M B Pepys
Journal:  Nature       Date:  1981-10-22       Impact factor: 49.962

7.  Binding of serum amyloid P-component (SAP) by amyloid fibrils.

Authors:  M B Pepys; R F Dyck; F C de Beer; M Skinner; A S Cohen
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

8.  Amyloid P-component is a constituent of normal human glomerular basement membrane.

Authors:  R F Dyck; C M Lockwood; M Kershaw; N McHugh; V C Duance; M L Baltz; M B Pepys
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

9.  Binding specificity of serum amyloid P component for the pyruvate acetal of galactose.

Authors:  C R Hind; P M Collins; D Renn; R B Cook; D Caspi; M L Baltz; M B Pepys
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

10.  Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component.

Authors:  F C de Beer; M L Baltz; S Holford; A Feinstein; M B Pepys
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  21 in total

1.  Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.

Authors:  G Zandman-Goddard; M Blank; P Langevitz; L Slutsky; M Pras; Y Levy; O Shovman; T Witte; A Doria; J Rovensky; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

2.  Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients.

Authors:  I J Sørensen; E Holm Nielsen; L Schrøder; A Voss; L Horváth; S E Svehag
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

3.  Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis.

Authors:  P N Hawkins; G A Tennent; P Woo; M B Pepys
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

4.  Accumulation and expression of serum amyloid P component in human atherosclerotic lesions.

Authors:  Zhiqing Song; Lei Cai; Ling Guo; Yoshitane Tsukamoto; Chikao Yutani; Xiang-An Li
Journal:  Atherosclerosis       Date:  2010-02-06       Impact factor: 5.162

5.  Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

Authors:  P N Hawkins; R Wootton; M B Pepys
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli.

Authors:  M B Pepys; S E Booth; G A Tennent; P J Butler; D G Williams
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component.

Authors:  T Stenstad; J H Magnus; K Syse; G Husby
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  Pentraxin binding to isolated rat liver nuclei.

Authors:  E G Shephard; P J Smith; S Coetzee; A F Strachan; F C de Beer
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

9.  Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?

Authors:  Julian D Gillmore; Winston L Hutchinson; Jeff Herbert; Alison Bybee; Daniel A Mitchell; Robert P Hasserjian; Ken-Ichi Yamamura; Misao Suzuki; Caroline A Sabin; Mark B Pepys
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

Review 10.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.